New Materials and Early Diagnostics Makes Possible Reversal of Decay
Denville, N.J. – July 8, 2008 – Lantis Laser Inc. (Pink Sheets: LLSR - News) (http://www.lantislaser.com). Fluoride and its protection against tooth decay are well documented. Its action is best on the smooth surfaces of teeth. So, what about all those pits and fissures on the biting surface where decay is most prevalent? Recently, a new generation of topical products has been developed that have the ability to remineralize enamel from the bottom up, therefore reversing that dreaded decay, but only when detected very early on.
The list of products that can be used to arrest or reverse the decay process include amorphous calcium phosphate, fluoride varnishes, fluoride rinses and disinfecting mouth rinses. For the successful implementation of these treatments, early detection of decay is essential but is difficult with present day dental diagnostics as no imaging modalities provide the level of resolution required for early detection so that minimally invasive treatment with topical products can be prescribed. This is a barrier to the wider adoption of Minimally Invasive Dentistry (MID) and the dental profession is fully aware of this.
According to Dr. Craig Gimbel, Executive Vice President of Clinical Affairs for Lantis Laser, Inc, “the introduction of Lantis’ Optical Coherence Tomography (OCT) Dental Imaging System ™ in the first quarter of 2009 will enable dentists to non-invasively image what they never were able to do before - the microstructure of teeth at a high resolution to detect early decay, using just light.”
Dr. Gimbel continued,” even x-rays are not capable of imaging early decay in those tiny pits and fissures. OCT will drive a new generation of MID and every dental office will require an OCT System to diagnose and treat very early decay.” Dr Gimbel points out “both the dentist and the patients they treat can only benefit. Early diagnosis means possibly you may avoid that dreaded dental drill.”
Research studies have shown that OCT technology can provide evidence for early decay demineralization and then follow the process of remineralizing, all without the risk of radiation.
Lantis’ OCT Dental Imaging System ™ is based on novel light-based, bio-medical imaging technology, Optical Coherence Tomography, that enables the dentist to do diagnostic imaging, chairside and in real-time. As the power source is light-based, unlike x-ray there is no harmful radiation. Images can be captured at a resolution of up to 10 times that of x-ray, enabling early detection of decay and detailed examination of microstructural defects.
About Lantis Laser
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 and Phase 3 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System(TM) in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); Lightlab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser (LLSR: PK), visit www.lantislaser.com
Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.
Company Contact:
Stan Baron, President & CEO
Lantis Laser Inc.
Tel: (203) 300-7622
sbaron@lantislaser.com
AGORACOM Investor Relations
http://www.agoracom.com/ir/lantislaser
llsr@agoracom.com
For OCT Updates
http://octnews.hivefire.com
